Terms: = Kidney tumors AND FUS, P35637, 2521, ENSG00000089280, TLS/CHOP, FUS-CHOP, CHOP, FUS1, TLS AND Prognosis
18 results:
1. Heterogeneity in tertiary lymphoid structures predicts distinct prognosis and immune microenvironment
Xu W; Lu J; Liu WR; Anwaier A; Wu Y; Tian X; Su JQ; Qu YY; Yang J; Zhang H; Ye D
J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38040418
[TBL] [Abstract] [Full Text] [Related]
2. Spatial heterogeneity of tumor microenvironment influences the prognosis of clear cell renal cell carcinoma.
Zhang D; Ni Y; Wang Y; Feng J; Zhuang N; Li J; Liu L; Shen W; Zheng J; Zheng W; Qian C; Shan J; Zhou Z
J Transl Med; 2023 Jul; 21(1):489. PubMed ID: 37474942
[TBL] [Abstract] [Full Text] [Related]
3. Prediction values of tertiary lymphoid structures in the prognosis of patients with left- and right-sided colon cancer: a multicenter propensity score-matched study.
Mao Y; Wang X; Xi L; Dong M; Song P; Miao J; Lu C; Sun S; Li Q; Yu C; Shen X
Int J Surg; 2023 Aug; 109(8):2344-2358. PubMed ID: 37247038
[TBL] [Abstract] [Full Text] [Related]
4. CD20
Wu Z; Zhou J; Xiao Y; Ming J; Zhou J; Dong F; Zhou X; Xu Z; Zhao X; Lei P; Huang T
Front Immunol; 2022; 13():865596. PubMed ID: 35634306
[TBL] [Abstract] [Full Text] [Related]
5. Unique characteristics of tertiary lymphoid structures in kidney clear cell carcinoma: prognostic outcome and comparison with bladder cancer.
Masuda T; Tanaka N; Takamatsu K; Hakozaki K; Takahashi R; Anno T; Kufukihara R; Shojo K; Mikami S; Shinojima T; Kakimi K; Tsunoda T; Aimono E; Nishihara H; Mizuno R; Oya M
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35314433
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic value, DNA variation and immunologic features of a tertiary lymphoid structure-related chemokine signature in clear cell renal cell carcinoma.
Xu W; Ma C; Liu W; Anwaier A; Tian X; Shi G; Qu Y; Wei S; Zhang H; Ye D
Cancer Immunol Immunother; 2022 Aug; 71(8):1923-1935. PubMed ID: 35043231
[TBL] [Abstract] [Full Text] [Related]
7. Chronic kidney disease linked to SARS-CoV-2 infection: a case report.
Tarris G; de Rougemont A; Estienney MA; Journet J; Lariotte AC; Aubignat D; Rebibou JM; De La Vega MF; Legendre M; Belliot G; Martin L
BMC Nephrol; 2021 Aug; 22(1):278. PubMed ID: 34376184
[TBL] [Abstract] [Full Text] [Related]
8. [Primary renal lymphoma: a clinical analysis of 5 cases].
Lu L; Shi HZ; Xiao ZJ; Wang D; Li CL
Zhonghua Yi Xue Za Zhi; 2018 May; 98(18):1443-1445. PubMed ID: 29804410
[No Abstract] [Full Text] [Related]
9. Management of tumour lysis syndrome during first-line palliative chemotherapy for high-volume colorectal cancer.
Gouveia HS; Lopes SO; Faria AL
BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29545434
[TBL] [Abstract] [Full Text] [Related]
10. Pazopanib-related tumor lysis syndrome in metastatic clear cell renal cell carcinoma: a case report.
van Kalleveen MW; Walraven M; Hendriks MP
Invest New Drugs; 2018 Jun; 36(3):513-516. PubMed ID: 29464464
[TBL] [Abstract] [Full Text] [Related]
11. The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma: An international multicenter study of 1532 patients treated with chemoimmunotherapy.
El-Galaly TC; Villa D; Michaelsen TY; Hutchings M; Mikhaeel NG; Savage KJ; Sehn LH; Barrington S; Hansen JW; Smith D; Rady K; Mylam KJ; Larsen TS; Holmberg S; Juul MB; Cordua S; Clausen MR; Jensen KB; Johnsen HE; Seymour JF; Connors JM; de Nully Brown P; Bøgsted M; Cheah CY
Eur J Cancer; 2017 Apr; 75():195-203. PubMed ID: 28237865
[TBL] [Abstract] [Full Text] [Related]
12. [Analysis of Clinical Feature and Treatment Outcome of Patients with Renal Diffuse Large B Cell Lymphoma].
Yang P; Jing HM; Zhao W; Hu K; Wan W; Tian L; Ke XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1737-1742. PubMed ID: 28024486
[TBL] [Abstract] [Full Text] [Related]
13. DNA polymerase iota (Pol ι) promotes invasion and metastasis of esophageal squamous cell carcinoma.
Zou S; Shang ZF; Liu B; Zhang S; Wu J; Huang M; Ding WQ; Zhou J
Oncotarget; 2016 May; 7(22):32274-85. PubMed ID: 27057634
[TBL] [Abstract] [Full Text] [Related]
14. Bilateral primary renal lymphoma: case report and bibliographic review.
Navas Martínez MC; Molina Escudero R; Soto Delgado M; Jiménez Romero ME; Jiménez Jiménez J
Arch Esp Urol; 2011 Nov; 64(9):904-7. PubMed ID: 22155879
[TBL] [Abstract] [Full Text] [Related]
15. Cervical extramedullary lymphomatoid granulomatosis.
Montano N; Lucantoni C; Larocca LM; Papacci F; Meglio M
J Clin Neurosci; 2011 Jun; 18(6):851-3. PubMed ID: 21489796
[TBL] [Abstract] [Full Text] [Related]
16. Primary renal lymphoma: report of three new cases and literature review.
Vázquez Alonso F; Sánchez Ramos C; Vicente Prados FJ; Pascual Geler M; Ruiz Carazo E; Becerra Massare P; Funes Padilla C; Rodríguez Herrera F; Cózar Olmo JM; Tallada Buñuel M
Arch Esp Urol; 2009 Jul; 62(6):461-5. PubMed ID: 19736375
[TBL] [Abstract] [Full Text] [Related]
17. Renal complications in oncologic patients.
Givens ML; Wethern J
Emerg Med Clin North Am; 2009 May; 27(2):283-91. PubMed ID: 19447312
[TBL] [Abstract] [Full Text] [Related]
18. Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein.
Zhang J; Frolov I; Russell SJ
J Gene Med; 2004 Oct; 6(10):1082-91. PubMed ID: 15368589
[TBL] [Abstract] [Full Text] [Related]
